Literature DB >> 8777969

Oxidized BAL fluid proteins in patients with interstitial lung diseases.

A G Lenz1, U Costabel, K L Maier.   

Abstract

Oxygen-derived free radicals, released by phagocytic cells, have been postulated to contribute to lung tissue damage. We therefore investigated oxidative damage to proteins from bronchoalveolar lavage fluid (BALF) as an indicator of oxidative stress and to assess antioxidant defences in the lungs. We examined BAL fluids from patients with interstitial lung diseases, such as idiopathic pulmonary fibrosis (IPF, nonsmokers (NS) and smokers (S)), sarcoidosis (SARC, nonsmokers), and asbestosis (ASB, ex-smokers (EXS)). The oxidation of BALF proteins is accompanied by the introduction of carbonyl groups into their amino acid side-chains and can be quantitated by labeling these groups with tritiated borohydride. The total lung content of oxidized proteins recovered by bronchoalveolar lavage (BAL) was 0.3 +/- 0.07 nmol carbonyl.mL-1 BALF (mean +/- SEM) in the NS control group (n = 9) and tended to be increased, in the asymptomatic S group (n = 8; 0.59 +/- 0.14 nmol.mL-1). This parameter was significantly elevated both in IPF-NS (n = 14; 0.84 +/- 0.2 nmol carbonyl.mL-1 BALF) and SARC-NS (n = 15; 0.73 +/- 0.16 nmol.mL-1) as compared with the NS control. On the contrary, in smoking patients with IPF (n = 6; 0.41 +/- 0.1 nmol carbonyl.mL-1 BALF) and also in ASB-EXS (n = 6; 0.37 +/- 0.06 nmol.mL-1) it was not different from NS controls. The total amount of oxidized proteins correlated positively with the absolute number of eosinophils (EOS) in IPF-NS, IPF-S and SARC, and also with absolute polymorphonuclear neutrophil (PMN) numbers in IPF-NS and IPF-S. In conclusion, oxidative damage of BALF proteins occurred in nonsmoking patients with IPF and SARC. The amount of oxidized bronchoalveolar lavage fluid protein may provide a quantitative assessment of oxygen burden, a balance between oxidant stress and antioxidant defences.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777969     DOI: 10.1183/09031936.96.09020307

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  29 in total

Review 1.  Expression profiling in granulomatous lung disease.

Authors:  Edward S Chen; David R Moller
Journal:  Proc Am Thorac Soc       Date:  2007-01

2.  Long term smoking with age builds up excessive oxidative stress in bronchoalveolar lavage fluid.

Authors:  K Nagai; T Betsuyaku; T Kondo; Y Nasuhara; M Nishimura
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 3.  Iron metabolism in the lower respiratory tract.

Authors:  F Mateos; J H Brock; J L Pérez-Arellano
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

Review 4.  Targeting NOX enzymes in pulmonary fibrosis.

Authors:  Louise Hecker; Jeff Cheng; Victor J Thannickal
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

5.  Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.

Authors:  Carmen Veith; Agnes W Boots; Musa Idris; Frederik-Jan van Schooten; Albert van der Vliet
Journal:  Antioxid Redox Signal       Date:  2019-04-05       Impact factor: 8.401

Review 6.  Antioxidants as potential therapeutics for lung fibrosis.

Authors:  Brian J Day
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

7.  Fibrosis of two: Epithelial cell-fibroblast interactions in pulmonary fibrosis.

Authors:  Norihiko Sakai; Andrew M Tager
Journal:  Biochim Biophys Acta       Date:  2013-03-14

8.  Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up.

Authors:  Wojciech J Piotrowski; Zofia Kurmanowska; Adam Antczak; Jerzy Marczak; Paweł Górski
Journal:  BMC Pulm Med       Date:  2010-04-27       Impact factor: 3.317

9.  Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis.

Authors:  Marialuisa Bocchino; Savina Agnese; Evelina Fagone; Silvia Svegliati; Domenico Grieco; Carlo Vancheri; Armando Gabrielli; Alessandro Sanduzzi; Enrico V Avvedimento
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

10.  Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis.

Authors:  Moises Selman; Hung-Mo Lin; Martha Montaño; Audrey L Jenkins; Andrea Estrada; Zhenwu Lin; Guirong Wang; Susan L DiAngelo; Xiaoxuan Guo; Todd M Umstead; C Max Lang; Annie Pardo; David S Phelps; Joanna Floros
Journal:  Hum Genet       Date:  2003-09-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.